Most Popular Stories
- Gloom for the pharma industry, yes. Doom? No
- FDA talks, but doctors don't necessarily listen
- Astellas scores highest in Japanese M&A bout
- As blockbuster drugs fade, so does TV advertising
- Women's own cells could blast breast cancer
- Botox delivers for Allergan, Dr. Reddy's sees big profit increase during quarter
- FDA commish counters industry critics on expert conflict rules
- Scoring winners and losers in Japan pharma M&A bout
- Idenix gets good news on hep C trial, but can't compete with Gilead
- AstraZeneca's R&D chief in China lays out $100M strategy
- Gilead shares surge as hep C drug scores a cure for big patient population
Webinars
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
Featured Jobs
-
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Regional Sales Manager - West Coast Based
Advanced BioScience Laboratories, Inc. - San Francisco or San Diego, CA -
Sr. Manager, Market Research Job
Celgene Corporation - Summit, NJ, US -
Sr. Director, Alliance Management Job
Celgene Corporation - Summit, NJ, US -
Senior/Principal Catheter Engineer
NinePoint Medical, Inc. - Cambridge, MA
Popular Topics
Events
- Wharton Health Care Business Conference
Feb 16-17 — Philadelphia, PA - 6th Vaccine and ISV Congress
October 14-16, 2012 — Shanghai, China - Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Just Released: New Trends in Preventive and Therapeutic Vaccine
Pfizer halts tremelimumab development
April 8, 2008 — 5:59am ET
Tools


SHARE
WITH: